The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)

Chronic Asthma Clinical Trial

Official title:
A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Bronchodilatory Effect of MK0476 in Patients With Chronic Asthma

Status Completed

Clinical Trial Summary

This study will test the safety and effectiveness of a range of doses of MK0476 (montelukast) compared to placebo on improved lung function in patients with chronic asthma.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00739297
Study type	Interventional
Source	Organon and Co
Contact
Status	Completed
Phase	Phase 1
Start date	July 2008
Completion date	December 2008

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04395937` - Effects of Regular Submaximal Exercise on Asthma Control and Quality of Life in Patients With Persistent Symptoms	N/A
Completed	`NCT01305369` - The Effect of Prasugrel on Bronchial Hyperreactivity and on Markers of Inflammation in Patients With Chronic Asthma	Phase 4
Not yet recruiting	`NCT06457009` - Impact of Multi-Component Intervention on Suspected Asthma Population	N/A
Completed	`NCT02386722` - Intervention to Improve Inhalative Adherence	N/A
Not yet recruiting	`NCT06163807` - Follow-up of Spanish Prospective Asthma and Nasal Polyposis Registry